NewslettersProstate Cell News Triggering Pyroptosis Enhances the Antitumor Efficacy of PARP Inhibitors in Prostate Cancer By Bob - August 25, 2023 0 Researchers demonstrated that GSDME activity was robustly induced in olaparib-treated cells undergoing pyroptosis, and that high methylation of the GSDME promoter dampened its activity in prostate cancer cells. [Cellular Oncology] Abstract